Angiomyolipoma medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 5: Line 5:


==Overview==
==Overview==
Treatment options include selective renal artery embolization,nephron sparing surgery( enucleation or partial nephrectomy), complete and radical nephrectomy, radio-frequency ablation and everolimus. Angiomyolipomas found incidentally,asymptomatic, < 4 cm in size, generally requires no intervention beside periodic evaluation.Medium sized lesion(4-8 cm) should be closely followed with the serial imaging studies and elective intervention provided if the change in the size or symptoms noticed to increases the chances of renal function salavage..Larger lesion(>8cm), shown to progress to the development of the complication so treated elective. Patients with loss of renal function should be monitored for:
* [[Hypertension]]
* Adverse effects of nephrotoxic drugs such as:
** [[NSAIDS]]
** IV contrast agents
Treatment and management of the [[Angiomyolipoma]] depends largely on  
Treatment and management of the [[Angiomyolipoma]] depends largely on  
* size of the tumors,  
# size of the tumors,  
* signs and symptoms,  
# signs and symptoms,  
* presence or absence of Life threatening hemorrhage,  
# presence or absence of Life threatening hemorrhage,  
* its association with the tuberous sclerosis and the presence of the comorbities.<ref name="pmid3520013">{{cite journal| author=Oesterling JE, Fishman EK, Goldman SM, Marshall FF| title=The management of renal angiomyolipoma. | journal=J Urol | year= 1986 | volume= 135 | issue= 6 | pages= 1121-4 | pmid=3520013 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3520013  }}</ref>
# its association with the tuberous sclerosis and the presence of the comorbities.<ref name="pmid3520013">{{cite journal| author=Oesterling JE, Fishman EK, Goldman SM, Marshall FF| title=The management of renal angiomyolipoma. | journal=J Urol | year= 1986 | volume= 135 | issue= 6 | pages= 1121-4 | pmid=3520013 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3520013  }}</ref>


==Medical Therapy==
==Medical Therapy==

Revision as of 06:46, 1 August 2018

Angiomyolipoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Angiomyolipoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Angiomyolipoma medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Angiomyolipoma medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Angiomyolipoma medical therapy

CDC on Angiomyolipoma medical therapy

Angiomyolipoma medical therapy in the news

Blogs on Angiomyolipoma medical therapy

Directions to Hospitals Treating Angiomyolipoma

Risk calculators and risk factors for Angiomyolipoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]

Overview

Treatment options include selective renal artery embolization,nephron sparing surgery( enucleation or partial nephrectomy), complete and radical nephrectomy, radio-frequency ablation and everolimus. Angiomyolipomas found incidentally,asymptomatic, < 4 cm in size, generally requires no intervention beside periodic evaluation.Medium sized lesion(4-8 cm) should be closely followed with the serial imaging studies and elective intervention provided if the change in the size or symptoms noticed to increases the chances of renal function salavage..Larger lesion(>8cm), shown to progress to the development of the complication so treated elective. Patients with loss of renal function should be monitored for:

Treatment and management of the Angiomyolipoma depends largely on

  1. size of the tumors,
  2. signs and symptoms,
  3. presence or absence of Life threatening hemorrhage,
  4. its association with the tuberous sclerosis and the presence of the comorbities.[1]

Medical Therapy

There is no medical treatment for angiomyolipoma. The mainstay of therapy is embolisation. Angiomyolipomas found incidentally usually require no therapy. Patients with loss of renal function should be monitored for:

References

  1. Oesterling JE, Fishman EK, Goldman SM, Marshall FF (1986). "The management of renal angiomyolipoma". J Urol. 135 (6): 1121–4. PMID 3520013.

Template:WikiDoc Sources